Kenvue reported first quarter 2026 net sales of $3.91 billion, a 4.5% year-over-year increase, and adjusted diluted EPS of $0.32, beating analyst estimates. The sales growth included a significant 3.8% benefit from foreign currency exchange rates.
Key Highlights
- Organic sales grew 0.7%, driven by a 1.0% increase from price/mix that was partially offset by a 0.3% decline in volume.
- The Skin Health and Beauty segment was a key driver, posting 5.0% organic sales growth, while the Self Care segment saw a 2.3% organic sales decline attributed to a weak cold and flu season.
- Adjusted operating income margin expanded significantly to 24.0% from 19.8% in the prior year, benefiting from productivity gains and cost optimization actions.
- The company did not provide forward-looking guidance due to its pending acquisition by Kimberly-Clark.